Nephrology and Urology

Our nephrology team has in-depth insight into the scientific methodology, competitive research landscape and key regulatory drivers to move product development forward quickly.

OUR RENAL AND NEPHROLOGY CLINICAL STUDY EXPERIENCE INCLUDES A RANGE OF INDICATIONS, SUCH AS

  • Chronic renal disease and end stage renal disease
  • Diabetic nephropathy
  • Hyperphosphatemia
  • Vasculitis (i.e., SLE)
  • Acute kidney injury
  • Anemia
  • Glomerulonephritis (i.e., IgA nephropathy and focal glomerulosclerosis)
  • Hyperoxaluria
  • Kidney transplantation
  • Polycystic kidney disease
  • Alport syndrome

PARTNER WITH A GLOBAL MULTI-SPECIALTY TEAM IN Nephrology and Urology DISEASE

Andy Bevan
Executive Director,
Peri- and Post-approval Studies

Andy Bevan
Executive Director,
Peri- and Post-approval Studies

Andy Bevan
Executive Director,
Peri- and Post-approval Studies

Andy Bevan
Executive Director,
Peri- and Post-approval Studies

PROMOTING CLINICAL RESEARCH ON RENAL DISEASES IN PRE- AND POST-APPROVAL SITUATIONS

Researchers examine novel medications or therapies in pre-approval clinical trials for kidney disorders using exacting study procedures meant to gauge their pharmacokinetics, pharmacodynamics, and clinical efficacy in patients at different stages of kidney failure. The goal of post-approval clinical research on renal illnesses is to assess approved medicines and interventions for real-world effectiveness, safety, and long-term safety.

KLCRO offers a comprehensive set of clinical research services including pharmaceuticals, alternative medicines, Biotechnological products, and medical devices.

Facebook Instagram Linkedin Youtube
Company
Support
Contact Info
Copyright © 2023 KLCRO, All rights reserved.